Market Overview

Herbalife Shares Edge Higher; Wedbush Boosts Target to $90, Analyst Shows No Concern on Nu Skin Product

Related HLF
Ackman: Allergan Is A Good Merger Arbitrage Play, Potential 28% Upside
Bill Ackman Says Herbalife's Business Is Declining
Global Jitters Send Wall Street Tumbling (Fox Business)
Related NUS
BTIG: Nu Skin's China Issues 'Are In The Past, But Will The Difference Be Demonstrated?'
Deutsche Bank: Nu Skin Enterprises 'Rebuilds' China Business
Herbalife Tumbles as FBI Probe Comes to Light (Fox Business)

Shares of Herbalife (NYSE: HLF) are trading up about a percent Friday morning as traders are cheering a boosted price target from Wedbush's Rommel Dionisio.

Dionisio now expects Herbalife shares to rise to $90 over the next year, up from $80 previously.

The analyst believes Herbalife will be buying back additional shares more aggressively on the heels of the recent re-audit conclusion. Dionisio noted the firm's distributor checks are indicating "not even a slight" slowdown in sales growth following the unveiling of a new Nu Skin (NYSE: NUS) product.

Wedbush maintains an Outperform rating on shares of Herbalife.

With Herbalife shares last trading around $79.50, Dionisio's new price target implies potential upside of about 13 percent.

Latest Ratings for HLF

DateFirmActionFromTo
Nov 2014BarclaysMaintainsOverweight
Nov 2014BTIG ResearchInitiates Coverage onBuy
Nov 2014SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for HLF
View the Latest Analyst Ratings

Posted-In: Analyst Color News Price Target Analyst Ratings

 

Related Articles (HLF + NUS)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional